Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
39.58
+1.79 (4.74%)
At close: Feb 17, 2026, 4:00 PM EST
39.00
-0.58 (-1.47%)
After-hours: Feb 17, 2026, 7:59 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $4.31 billion as of February 17, 2026. Its market cap has increased by 992.32% in one year.
Market Cap
4.31B
Enterprise Value
4.01B
1-Year Change
992.32%
Ranking
Category
Stock Price
$39.58
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $4.31B, an increase of 2,897.70%. That is a compound annual growth rate of 96.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.11B | -6.46% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 4.57B |
| Amicus Therapeutics | 4.49B |
| Crinetics Pharmaceuticals | 4.38B |
| Corcept Therapeutics | 4.20B |
| TG Therapeutics | 4.17B |
| CG Oncology | 4.15B |
| Arcellx | 3.96B |
| NewAmsterdam Pharma Company | 3.93B |